Coagulation and thromboembolic complications in the nephrotic syndrome.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000925:Anticoagulants / Q000627:therapeutic use; D000990:Antithrombin III / Q000032:analysis; D001157:Arterial Occlusive Diseases / Q000209:etiology; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001779:Blood Coagulation Factors / Q000502:physiology; D001792:Blood Platelets / Q000502:physiology; D002648:Child; D006801:Humans; D007223:Infant; D008074:Lipoproteins / Q000097:blood; D008177:Lupus Vulgaris / Q000276:immunology; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology; D009404:Nephrotic Syndrome / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D010974:Platelet Aggregation; D011655:Pulmonary Embolism / Q000209:etiology*; D012082:Renal Veins / Q000503:physiopathology; D013924:Thrombophlebitis / Q000209:etiology; D013927:Thrombosis / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D001779:Blood Coagulation Factors; D008074:Lipoproteins; D000990:Antithrombin III